Suppr超能文献

研究阿萨伊果(Euterpe oleracea)对血脂谱的影响:一项全面的系统评价和荟萃分析。

Investigating the Impact of Açai (Euterpe oleracea) on Lipid Profile: A Comprehensive Systematic Review and Meta-Analysis.

作者信息

Candeloro Bruno Moreira, Bitencourt Túlio H B, Elias Sergio F R, Rauli Maria Clara, Brandão Isabela B, Barbalho Sandra Maria, Garner David M, Raimundo Rodrigo D, Porto Andrey A, Valenti Vitor E

机构信息

School of Philosophy and Sciences, Systematic Reviews Center for Cardiovascular and Metabolic Health, São Paulo State University, Marília, São Paulo, Brazil.

Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília, São Paulo, Brazil.

出版信息

Nutr Bull. 2025 Jun;50(2):206-219. doi: 10.1111/nbu.12735. Epub 2025 Feb 17.

Abstract

Conditions such as obesity and cardiovascular diseases represent significant global public health challenges, driven by their increasing prevalence and profound effects on morbidity and mortality. Dyslipidemia, defined by abnormal lipid concentrations, performs a pivotal role in the onset of cardiovascular diseases, especially atherosclerosis. Dietary strategies and other nonpharmacological interventions are crucial for the management of dyslipidemia. Açaí (Euterpe oleracea), a fruit native to the Amazon, is recognised for its antioxidant properties and potential impact on lipid metabolism. This systematic review and meta-analysis aimed to assess the impact of açaí consumption on lipid profile markers. A systematic search was performed across several databases, including MEDLINE/PubMed, EMBASE, Web of Science and Scopus. We included non-randomised, randomised, no blind, blind and control trials involving adult participants who received açaí in any form. The outcome measures included triglycerides, total cholesterol, LDL-c and HDL-c. The screening of studies and data extraction were independently conducted by four reviewers. The risk of bias was evaluated using the Cochrane Risk of Bias tool, and meta-analyses were completed where applicable. Out of 188 identified studies, 8 met the inclusion criteria. Meta-analysis of 411 participants displayed no significant effect of açaí on LDL-c (MD = 6.06 mg/dL 95% CI: -0.03, 12.48, p = 0.06), HDL-c (MD = 0.30 mg/dL 95% CI: -1.54, 2.13, p = 0.75), total cholesterol (MD = 2.94 mg/dL 95% CI: -6.44, 12.31, p = 0.54) and triglycerides (MD = 2.05 mg/dL 95% CI: 1.79, 2.28, p = 0.59). Additionally, açaí consumption was related to a significant reduction in total lipids (MD = -9.80 g, 95% CI: -13.94 to -5.66, p < 0.001). GRADE evaluation pointed to low/very low certainty of evidence. Açaí consumption may lessen total lipid levels, but no significant effect was noted for cholesterol parameters and triglycerides. Further trials with more demanding research methodologies are required to clarify the effects of açaí on lipid profiles. Trial Registration: CRD42024549531.

摘要

肥胖和心血管疾病等状况是重大的全球公共卫生挑战,其患病率不断上升且对发病率和死亡率产生深远影响。血脂异常由异常的脂质浓度定义,在心血管疾病尤其是动脉粥样硬化的发病中起关键作用。饮食策略和其他非药物干预对血脂异常的管理至关重要。阿萨伊果(Euterpe oleracea)是一种原产于亚马逊的水果,以其抗氧化特性和对脂质代谢的潜在影响而闻名。本系统评价和荟萃分析旨在评估食用阿萨伊果对脂质谱标志物的影响。在包括MEDLINE/PubMed、EMBASE、科学网和Scopus在内的多个数据库中进行了系统检索。我们纳入了涉及成年参与者的非随机、随机、非盲、盲法和对照试验,这些参与者以任何形式食用了阿萨伊果。结局指标包括甘油三酯、总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇。由四位评审员独立进行研究筛选和数据提取。使用Cochrane偏倚风险工具评估偏倚风险,并在适用时完成荟萃分析。在188项已识别的研究中,8项符合纳入标准。对411名参与者的荟萃分析显示,阿萨伊果对低密度脂蛋白胆固醇(MD = 6.06mg/dL,95%CI:-0.03,12.48,p = 0.06)、高密度脂蛋白胆固醇(MD = 0.30mg/dL,95%CI:-1.54,2.13,p = 0.75)、总胆固醇(MD = 2.94mg/dL,95%CI:-6.44,12.31,p = 0.54)和甘油三酯(MD = 2.05mg/dL,95%CI:1.79,2.28,p = 0.59)均无显著影响。此外,食用阿萨伊果与总脂质显著降低有关(MD = -9.80g,95%CI:-13.94至-5.66,p < 0.001)。GRADE评估表明证据的确定性为低/极低。食用阿萨伊果可能会降低总脂质水平,但对胆固醇参数和甘油三酯未观察到显著影响。需要采用更严格研究方法的进一步试验来阐明阿萨伊果对脂质谱的影响。试验注册号:CRD42024549531。

相似文献

2
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2014;2014(12):CD010405. doi: 10.1002/14651858.CD010405.pub2. Epub 2014 Dec 4.
4
Treatment for women with postpartum iron deficiency anaemia.
Cochrane Database Syst Rev. 2024 Dec 13;12(12):CD010861. doi: 10.1002/14651858.CD010861.pub3.
5
Omega 6 fatty acids for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2015 Nov 16(11):CD011094. doi: 10.1002/14651858.CD011094.pub2.
6
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
10
Interventions implemented through sporting organisations for promoting healthy behaviour or improving health outcomes.
Cochrane Database Syst Rev. 2025 Jan 13;1(1):CD012170. doi: 10.1002/14651858.CD012170.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验